Kelly Wilson
Operationeel Directeur bij BIOSTAX CORP.
Vermogen: 733 599 $ op 30-04-2024
Profiel
Kelly O’Brien Wilson currently works at Forte Animal Health, Inc., as Director from 2020 and Biostax Corp., as Chief Operating Officer from 2022.
Ms. Wilson also formerly worked at Biostax Corp., as CTO & Director-Human Resources from 2015 to 2020, Biostax Corp., as Chief Executive & Operating Officer in 2023, and Cytocom, Inc., as Chief Technology & Information Officer from 2016 to 2020.
Ms. Wilson received her undergraduate degree and graduate degree from the University of Central Florida.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
BIOSTAX CORP
18.64% | 28-03-2024 | 15 608 498 ( 18.64% ) | 733 599 $ | 30-04-2024 |
Actieve functies van Kelly Wilson
Bedrijven | Functie | Begin |
---|---|---|
BIOSTAX CORP. | Operationeel Directeur | 01-08-2022 |
Forte Animal Health, Inc. | Directeur/Bestuurslid | 01-12-2020 |
Eerdere bekende functies van Kelly Wilson
Bedrijven | Functie | Einde |
---|---|---|
BIOSTAX CORP. | Algemeen Directeur | 25-07-2023 |
BIOSTAX CORP. | Hoofd Techniek/Wetenschap/O&O | 01-04-2020 |
Cytocom, Inc. /Old/
Cytocom, Inc. /Old/ BiotechnologyHealth Technology Cytocom, Inc. operates as biotech company which specializes in repurposing of drugs that deploys patented therapies and develops novel immune therapies. The company was founded by Noreen M. Griffin and is headquartered in Winter Park, FL. | Hoofd Techniek/Wetenschap/O&O | 01-04-2020 |
Opleiding van Kelly Wilson
University of Central Florida | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
BIOSTAX CORP. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Cytocom, Inc. /Old/
Cytocom, Inc. /Old/ BiotechnologyHealth Technology Cytocom, Inc. operates as biotech company which specializes in repurposing of drugs that deploys patented therapies and develops novel immune therapies. The company was founded by Noreen M. Griffin and is headquartered in Winter Park, FL. | Health Technology |
Forte Animal Health, Inc. |